SCHEMBL24068232

SCHEMBL24068232

CC(C)(O)[C@@H]1CC[C@](C)([C@H]2[C@@H](O)C[C@@]3(C)[C@H]4C[C@H](O)C5C(C)(C)[C@@H](O)CC[C@@]56C[C@@]46CC[C@]23C)O1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 4/20 0.58
▸ PPARG P37231 1/20 0.39
▸ ABCB1 P08183 1/20 0.39
▸ PTPN1 P18031 1/20 0.38
▸ ATP1A1 P05023 1/20 0.38
▸ ATP1B1 P05026 1/20 0.38
▸ ATP1A3 P13637 1/20 0.38
▸ ATP1B2 P14415 1/20 0.38
▸ ATP1A2 P50993 1/20 0.38
▸ ATP1B3 P54709 1/20 0.38
▸ FXYD2 P54710 1/20 0.38
▸ ATP1A4 Q13733 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ABCC1 P33527 1/20 0.32
▸ PSEN1 P49768 1/20 0.32
▸ PSEN2 P49810 1/20 0.32
▸ APH1B Q8WW43 1/20 0.32
▸ NCSTN Q92542 1/20 0.32
▸ APH1A Q96BI3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19954688 1.00 TYR (0.58) TYRPPARGABCB1PTPN1ATP1A1
SCHEMBL13035585 1.00 TYR (0.58) TYRPPARGABCB1PTPN1ATP1A1
SCHEMBL13076516 1.00 TYR (0.58) TYRPPARGABCB1PTPN1ATP1A1
SCHEMBL14647711 1.00 TYR (0.58) TYRPPARGABCB1PTPN1ATP1A1
SCHEMBL20635922 1.00 TYR (0.58) TYRPPARGABCB1PTPN1ATP1A1
SCHEMBL24498092 1.00 TYR (0.58) TYRPPARGABCB1PTPN1ATP1A1
SCHEMBL14446466 1.00 TYR (0.58) TYRPPARGABCB1PTPN1ATP1A1
SCHEMBL19954628 1.00 TYR (0.58) TYRPPARGABCB1PTPN1ATP1A1
SCHEMBL22853929 1.00 TYR (0.58) TYRPPARGABCB1PTPN1ATP1A1
SCHEMBL12764255 1.00 TYR (0.58) TYRPPARGABCB1PTPN1ATP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210369738-A1 PRODUCTION METHOD OF TELOMERASE ACTIVATORS AND TELOMERASE ACTIVATORS OBTAINED BY THIS METHOD IZMIR YUKSEK TEKNOLOJI ENSTITUSU (TR) 2021-12-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210369738-A1 PRODUCTION METHOD OF TELOMERASE ACTIVATORS AND TELOMERASE ACTIVATORS OBTAINED BY THIS METHOD TERT, TERB1, TERF2 TYR 455/4885PPARG 3337/4885ABCB1 1940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback